{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T11:14:50Z","timestamp":1792494890284,"version":"4.5.0"},"reference-count":46,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,8,1]]},"abstract":"<jats:p>INTRODUCTION: Most polyvinylchloride infusion systems are plasticized with up to 60% of di(2-ethylhexyl)phthalate (DEHP). DEHP is easily extracted from the tubing by total parenteral nutrition (TPN) solutions and has been shown to have toxic effects on various organ systems including the liver in animals and humans. A role was postulated for DEHP in the development of hepatobiliary dysfunction in premature and newborn infants receiving parenteral nutrition, and the incidence of cholestasis was investigated after changing from polyvinylchloride infusion systems to polyvinylchloride-free infusion systems.<\/jats:p><jats:p>MATERIALS AND METHODS: Two 3-year periods from 1998 to 2004 were investigated retrospectively before and after changing from polyvinylchloride to polyvinylchloride-free infusion systems in our department. This resulted in 1 group of 30 patients treated with polyvinylchloride lines and a second group of 46 patients treated with polyvinylchloride-free lines. The 2 groups were examined for the incidence of cholestasis and other possible contributing factors. Statistics were performed by using SAS software (SAS Institute, Cary, NC).<\/jats:p><jats:p>RESULTS: After changing infusion systems, the incidence of cholestasis dropped from 50% to 13%. Using DEHP-plasticized polyvinylchloride infusion systems for TPN increased the risk for cholestasis by a factor of 5.6. The use of polyvinylchloride lines correlated strongly with the development of TPN-associated cholestasis (P = .0004).<\/jats:p><jats:p>CONCLUSIONS: Using DEHP-containing polyvinylchloride infusions systems contributes to the development of cholestasis. Therefore, the use of DEHP-free infusion systems for TPN is recommended, especially in premature and newborn infants.<\/jats:p>","DOI":"10.1542\/peds.2008-1765","type":"journal-article","created":{"date-parts":[[2009,7,27]],"date-time":"2009-07-27T11:32:55Z","timestamp":1248694375000},"page":"710-716","source":"Crossref","is-referenced-by-count":57,"title":["Use of Di(2-Ethylhexyl)Phthalate\u2013Containing Infusion Systems Increases the Risk for Cholestasis"],"prefix":"10.1542","volume":"124","author":[{"given":"Heike","family":"von Rettberg","sequence":"first","affiliation":[{"name":"Department of Pediatric Surgery"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Hannman","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery, Klinikum Stuttgart, Stuttgart, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Subotic","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery, Inselspital Bern, University of Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Brade","sequence":"additional","affiliation":[{"name":"Institute of Biometrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Schaible","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University Hospital Mannheim, Mannheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl Ludwig","family":"Waag","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffan","family":"Loff","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery, Klinikum Stuttgart, Stuttgart, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2009,8,1]]},"reference":[{"key":"2021120905300509700_R1","doi-asserted-by":"crossref","unstructured":"Beale EF, Nelson RM, Bucciarelli RL, Donnelly WH, Eitzman DV. Intrahepatic cholestasis associated with parenteral nutrition in premature infants. Pediatrics.\u20081979;64(3):342\u2013347","DOI":"10.1542\/peds.64.3.342"},{"key":"2021120905300509700_R2","unstructured":"Balistreri WF BK. Hepatobiliary Consequences of Parenteral Alimentation. Philadelphia, PA: Saunders; 1990"},{"key":"2021120905300509700_R3","doi-asserted-by":"crossref","unstructured":"Merritt RJ. Cholestasis associated with total parenteral nutrition. J Pediatr Gastroenterol Nutr.\u20081986;5(1):9\u201322","DOI":"10.1097\/00005176-198601000-00004"},{"key":"2021120905300509700_R4","doi-asserted-by":"crossref","unstructured":"Quigley EM, Marsh MN, Shaffer JL, Markin RS. Hepatobiliary complications of total parenteral nutrition. Gastroenterology.\u20081993;104(1):286\u2013301","DOI":"10.1016\/0016-5085(93)90864-9"},{"key":"2021120905300509700_R5","doi-asserted-by":"crossref","unstructured":"Benjamin DR. Hepatobiliary dysfunction in infants and children associated with long-term total parenteral nutrition: a clinico-pathologic study. Am J Clin Pathol.\u20081981;76(3):276\u2013283","DOI":"10.1093\/ajcp\/76.3.276"},{"key":"2021120905300509700_R6","doi-asserted-by":"crossref","unstructured":"Moss RL, Amii LA. New approaches to understanding the etiology and treatment of total parenteral nutrition-associated cholestasis. Semin Pediatr Surg.\u20081999;8(3):140\u2013147","DOI":"10.1016\/S1055-8586(99)70015-6"},{"key":"2021120905300509700_R7","doi-asserted-by":"crossref","unstructured":"Rintala R, Lindahl H, Pohjavuori M, Saxen H, Sariola H. Surgical treatment of intractable cholestasis associated with total parenteral nutrition in premature infants. J Pediatr Surg.\u20081993;28(5):716\u2013719","DOI":"10.1016\/0022-3468(93)90040-R"},{"key":"2021120905300509700_R8","doi-asserted-by":"crossref","unstructured":"Hodes JE, Grosfeld JL, Weber TR, Schreiner RL, Fitzgerald JF, Mirkin LD. Hepatic failure in infants on total parenteral nutrition (TPN): clinical and histopathologic observations. J Pediatr Surg.\u20081982;17(5):463\u2013468","DOI":"10.1016\/S0022-3468(82)80090-0"},{"key":"2021120905300509700_R9","doi-asserted-by":"crossref","unstructured":"Moss RL, Das JB, Raffensperger JG. Total parenteral nutrition-associated cholestasis: clinical and histopathologic correlation. J Pediatr Surg.\u20081993;28(10):1270\u20131274; discussion 1274\u20131275","DOI":"10.1016\/S0022-3468(05)80311-2"},{"key":"2021120905300509700_R10","doi-asserted-by":"crossref","unstructured":"Rintala RJ, Lindahl H, Pohjavuori M. Total parenteral nutrition-associated cholestasis in surgical neonates may be reversed by intravenous cholecystokinin: a preliminary report. J Pediatr Surg.\u20081995;30(6):827\u2013830","DOI":"10.1016\/0022-3468(95)90758-0"},{"key":"2021120905300509700_R11","doi-asserted-by":"crossref","unstructured":"Lester R. Physiologic cholestasis. Gastroenterology.\u20081980;78(4):864\u2013865","DOI":"10.1016\/0016-5085(80)90693-9"},{"key":"2021120905300509700_R12","doi-asserted-by":"crossref","unstructured":"Watkins JB, Szczepanik P, Gould JB, Klein P, Lester R. Bile salt metabolism in the human premature infant: preliminary observations of pool size and synthesis rate following prenatal administration of dexamethasone and phenobarbital. Gastroenterology.\u20081975;69(3):706\u2013713","DOI":"10.1016\/S0016-5085(19)32473-4"},{"key":"2021120905300509700_R13","doi-asserted-by":"crossref","unstructured":"Watkins JB, Ingall D, Szczepanik P, Klein PD, Lester R. Bile-salt metabolism in the newborn: measurement of pool size and synthesis by stable isotope technic. N Engl J Med.\u20081973;288(9):431\u2013434","DOI":"10.1056\/NEJM197303012880902"},{"key":"2021120905300509700_R14","doi-asserted-by":"crossref","unstructured":"Balistreri WF, Heubi JE, Suchy FJ. Immaturity of the enterohepatic circulation in early life: factors predisposing to \u201cphysiologic\u201d maldigestion and cholestasis. J Pediatr Gastroenterol Nutr.\u20081983;2(2):346\u2013354","DOI":"10.1097\/00005176-198305000-00025"},{"key":"2021120905300509700_R15","doi-asserted-by":"crossref","unstructured":"Pin\u0303eiro-Carrero VM, Pin\u0303eiro EO. Liver. Pediatrics.\u20082004;113(4 suppl):1097\u20131106","DOI":"10.1542\/peds.113.S3.1097"},{"key":"2021120905300509700_R16","doi-asserted-by":"crossref","unstructured":"Seo KW, Kim KB, Kim YJ, Choi JY, Lee KT, Choi KS. Comparison of oxidative stress and changes of xenobiotic metabolizing enzymes induced by phthalates in rats. Food Chem Toxicol.\u20082004;42(1):107\u2013114","DOI":"10.1016\/j.fct.2003.08.010"},{"key":"2021120905300509700_R17","doi-asserted-by":"crossref","unstructured":"Calafat AM, Needham LL, Silva MJ, Lambert G. Exposure to di-(2-ethylhexyl) phthalate among premature neonates in a neonatal intensive care unit. Pediatrics.\u20082004;113(5). Available at: www.pediatrics.org\/cgi\/content\/full\/113\/5\/e429","DOI":"10.1542\/peds.113.5.e429"},{"key":"2021120905300509700_R18","doi-asserted-by":"crossref","unstructured":"Sjo\u0308berg P, Bondesson U, Sedin G, Gustafsson J. Dispositions of di- and mono-(2-ethylhexyl) phthalate in newborn infants subjected to exchange transfusions. Eur J Clin Invest.\u20081985;15(6):430\u2013436","DOI":"10.1111\/j.1365-2362.1985.tb00297.x"},{"key":"2021120905300509700_R19","doi-asserted-by":"crossref","unstructured":"Sjo\u0308berg PO, Bondesson UG, Sedin EG, Gustafsson JP. Exposure of newborn infants to plasticizers: plasma levels of di-(2-ethylhexyl) phthalate and mono-(2-ethylhexyl) phthalate during exchange transfusion. Transfusion.\u20081985;25(5):424\u2013428","DOI":"10.1046\/j.1537-2995.1985.25586020115.x"},{"key":"2021120905300509700_R20","unstructured":"Loff S, Kabs F, Witt K, Hosie S, Waag KL. Extraction of plasticizer from PVC-infusion lines for newborn intensive care units (in German). Z Erna\u0308hrungso\u0308kol.\u20082000;1(1):19\u201324"},{"key":"2021120905300509700_R21","doi-asserted-by":"crossref","unstructured":"Rock G, Labow RS, Franklin C, Burnett R, Tocchi M. Hypotension and cardiac arrest in rats after infusion of mono(2-ethylhexyl) phthalate (MEHP), a contaminant of stored blood. N Engl J Med.\u20081987;316(19):1218\u20131219","DOI":"10.1056\/NEJM198705073161915"},{"key":"2021120905300509700_R22","doi-asserted-by":"crossref","unstructured":"Peck CC, Albro PW. Toxic potential of the plasticizer Di(2-ethylhexyl) phthalate in the context of its disposition and metabolism in primates and man. Environ Health Perspect.\u20081982;45(11):11\u201317","DOI":"10.1289\/ehp.824511"},{"key":"2021120905300509700_R23","unstructured":"Scientific Committee on Toxicity, Ecotoxicity, and the Environment. Opinion on phthalate migration from soft PVC toys and child-care articles. Presented at: 6th Scientific Committee on Toxicity, Ecotoxicity, and the Environment plenary meeting; November 26 and 27, 1998; Brussels, Belgium"},{"key":"2021120905300509700_R24","unstructured":"Scientific Committee on Toxicity, Ecotoxicity, and the Environment. Opinion on the results of a second risk assessment of bi(2-ethylhexyl)phthalate (DEHP) human health part. Presented at: 41st Scientific Committee on Toxicity, Ecotoxicity, and the Environment plenary meeting; January 8, 2004; Brussels, Belgium"},{"key":"2021120905300509700_R25","doi-asserted-by":"crossref","unstructured":"Loff S, Kabs F, Witt K, et al. Polyvinylchloride infusion lines expose infants to large amounts of toxic plasticizers. J Pediatr Surg.\u20082000;35(12):1775\u20131781","DOI":"10.1053\/jpsu.2000.19249"},{"key":"2021120905300509700_R26","doi-asserted-by":"crossref","unstructured":"Loff S, Subotic U, Reinicke F, Wischmann H, Brade J. Extraction of Di-ethylhexyl-phthalate from perfusion lines of various material, length and brand by lipid emulsions. J Pediatr Gastroenterol Nutr.\u20082004;39(4):341\u2013345","DOI":"10.1097\/00005176-200410000-00008"},{"key":"2021120905300509700_R27","doi-asserted-by":"crossref","unstructured":"Crocker JF, Safe SH, Acott P. Effects of chronic phthalate exposure on the kidney. J Toxicol Environ Health.\u20081988;23(4):433\u2013444","DOI":"10.1080\/15287398809531126"},{"key":"2021120905300509700_R28","doi-asserted-by":"crossref","unstructured":"Sjo\u0308berg P, Lindquist NG, Montin G, Ploen L. Effects of repeated intravenous infusions of the plasticizer di-(2-ethylhexyl) phthalate in young male rats. Arch Toxicol.\u20081985;58(2):78\u201383","DOI":"10.1007\/BF00348313"},{"key":"2021120905300509700_R29","doi-asserted-by":"crossref","unstructured":"Barry YA, Labow RS, Rock G, Keon WJ. Cardiotoxic effects of the plasticizer metabolite, mono (2-ethylhexyl)phthalate (MEHP), on human myocardium. Blood.\u20081988;72(4):1438\u20131439","DOI":"10.1182\/blood.V72.4.1438b.bloodjournal7241438b"},{"key":"2021120905300509700_R30","unstructured":"Jacobson MS, Kevy SV, Grand RJ. Effects of a plasticizer leached from polyvinyl chloride on the subhuman primate: a consequence of chronic transfusion therapy. J Lab Clin Med.\u20081977;89(5):1066\u20131079"},{"key":"2021120905300509700_R31","doi-asserted-by":"crossref","unstructured":"Jansen PL, Peters WH, Lamers WH. Hereditary chronic conjugated hyperbilirubinemia in mutant rats caused by defective hepatic anion transport. Hepatology.\u20081985;5(4):573\u2013579","DOI":"10.1002\/hep.1840050408"},{"key":"2021120905300509700_R32","doi-asserted-by":"crossref","unstructured":"Rusyn I, Peters JM, Cunningham ML. Modes of action and species-specific effects of di-(2-ethylhexyl)phthalate in the liver. Crit Rev Toxicol.\u20082006;36(5):459\u2013479","DOI":"10.1080\/10408440600779065"},{"key":"2021120905300509700_R33","doi-asserted-by":"crossref","unstructured":"Badr MZ. Induction of peroxisomal enzyme activities by di-(2-ethylhexyl) phthalate in thyroidectomized rats with parathyroid replants. J Pharmacol Exp Ther.\u20081992;263(3):1105\u20131110","DOI":"10.1016\/S0022-3565(25)10446-1"},{"key":"2021120905300509700_R34","doi-asserted-by":"crossref","unstructured":"Lazarow PB. Three hypolipidemic drugs increase hepatic palmitoyl-coenzyme A oxidation in the rat. Science.\u20081977;197(4303):580\u2013581","DOI":"10.1126\/science.195342"},{"key":"2021120905300509700_R35","unstructured":"Furukawa K, Numoto S, Furuya K, Furukawa NT, Williams GM. Effects of the hepatocarcinogen nafenopin, a peroxisome proliferator, on the activities of rat liver glutathione-requiring enzymes and catalase in comparison to the action of phenobarbital. Cancer Res.\u20081985;45(10):5011\u20135019"},{"key":"2021120905300509700_R36","doi-asserted-by":"crossref","unstructured":"Reddy JK. Carcinogenicity of peroxisome proliferators: evaluation and mechanisms. Biochem Soc Trans.\u20081990;18(1):92\u201394","DOI":"10.1042\/bst0180092"},{"key":"2021120905300509700_R37","doi-asserted-by":"crossref","unstructured":"Reddy JK, Azarnoff DL, Hignite CE. Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens. Nature.\u20081980;283(5745):397\u2013398","DOI":"10.1038\/283397a0"},{"key":"2021120905300509700_R38","doi-asserted-by":"crossref","unstructured":"Green S. PPAR: a mediator of peroxisome proliferator action. Mutat Res.\u20081995;333(1\u20132):101\u2013109","DOI":"10.1016\/0027-5107(95)00136-0"},{"key":"2021120905300509700_R39","doi-asserted-by":"crossref","unstructured":"Varanasi U, Chu R, Huang Q, Castellon R, Yeldandi AV, Reddy JK. Identification of a peroxisome proliferator-responsive element upstream of the human peroxisomal fatty acyl coenzyme A oxidase gene. J Biol Chem.\u20081996;271(4):2147\u20132155","DOI":"10.1074\/jbc.271.4.2147"},{"key":"2021120905300509700_R40","doi-asserted-by":"crossref","unstructured":"Takeshita A, Koibuchi N, Oka J, Taguchi M, Shishiba Y, Ozawa Y. Bisphenol-A, an environmental estrogen, activates the human orphan nuclear receptor, steroid and xenobiotic receptor-mediated transcription. Eur J Endocrinol.\u20082001;145(4):513\u2013517","DOI":"10.1530\/eje.0.1450513"},{"key":"2021120905300509700_R41","doi-asserted-by":"crossref","unstructured":"Voskoboinik I, Drew R, Ahokas JT. Differential effect of peroxisome proliferators on rat glutathione S-transferase isoenzymes. Toxicol Lett.\u20081996;87(2\u20133):147\u2013155","DOI":"10.1016\/0378-4274(96)03371-1"},{"key":"2021120905300509700_R42","doi-asserted-by":"crossref","unstructured":"Mehrotra K, Morgenstern R, Lundqvist G, Becedas L, Bengtsson Ahlberg M, Georgellis A. Effects of peroxisome proliferators and\/or hypothyroidism on xenobiotic-metabolizing enzymes in rat testis. Chem Biol Interact.\u20081997;104(2\u20133):131\u2013145","DOI":"10.1016\/S0009-2797(97)00020-3"},{"key":"2021120905300509700_R43","doi-asserted-by":"crossref","unstructured":"Green R, Hauser R, Calafat AM, et al. Use of di(2-ethylhexyl) phthalate-containing medical products and urinary levels of mono(2-ethylhexyl) phthalate in neonatal intensive care unit infants. Environ Health Perspect.\u20082005;113(9):1222\u20131225","DOI":"10.1289\/ehp.7932"},{"key":"2021120905300509700_R44","doi-asserted-by":"crossref","unstructured":"Koch HM, Preuss R, Angerer J. Di(2-ethylhexyl)phthalate (DEHP): human metabolism and internal exposure: an update and latest results. Int J Androl.\u20082006;29(1):155\u2013165; discussion 181\u2013185","DOI":"10.1111\/j.1365-2605.2005.00607.x"},{"key":"2021120905300509700_R45","doi-asserted-by":"crossref","unstructured":"Rock G, Tocchi M, Ganz PR, Tackaberry ES. Incorporation of plasticizer into red cells during storage. Transfusion.\u20081984;24(6):493\u2013498","DOI":"10.1046\/j.1537-2995.1984.24685066808.x"},{"key":"2021120905300509700_R46","doi-asserted-by":"crossref","unstructured":"Loff PD, Subotic U, Oulmi-Kagermann J, Kranzlin B, Reinecke MF, Staude C. Diethylhexylphthalate extracted by typical newborn lipid emulsions from polyvinylchloride infusion systems causes significant changes in histology of rabbit liver. JPEN J Parenter Enteral Nutr.\u20082007;31(3):188\u2013193","DOI":"10.1177\/0148607107031003188"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/124\/2\/710\/1103344\/zpe00809000710.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/124\/2\/710\/1103344\/zpe00809000710.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T12:51:46Z","timestamp":1739278306000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/124\/2\/710\/72393\/Use-of-Di-2-Ethylhexyl-Phthalate-Containing"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,1]]},"references-count":46,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2009,8,1]]},"published-print":{"date-parts":[[2009,8,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2008-1765","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,1]]}}}